Brian E. Mcdowell

Array ( [id] => 5721302 [patent_doc_number] => 20060074078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/272304 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6083 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074078.pdf [firstpage_image] =>[orig_patent_app_number] => 11272304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880400 [patent_doc_number] => 20080153783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use' [patent_app_type] => utility [patent_app_number] => 10/585504 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31348 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153783.pdf [firstpage_image] =>[orig_patent_app_number] => 10585504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441846 [patent_doc_number] => 20090093485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 11/718214 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26336 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093485.pdf [firstpage_image] =>[orig_patent_app_number] => 11718214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880423 [patent_doc_number] => 20080153806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Novel Diazabicyclic Aryl Derivatives And Their Medical Use' [patent_app_type] => utility [patent_app_number] => 11/665387 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8662 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153806.pdf [firstpage_image] =>[orig_patent_app_number] => 11665387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728072 [patent_doc_number] => 20080207616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Quinoxalines as B Baf Inhhibitors' [patent_app_type] => utility [patent_app_number] => 11/577132 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29110 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207616.pdf [firstpage_image] =>[orig_patent_app_number] => 11577132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361680 [patent_doc_number] => 20090036474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Quinazoline derivatives for use against cancer' [patent_app_type] => utility [patent_app_number] => 11/665115 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88721 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036474.pdf [firstpage_image] =>[orig_patent_app_number] => 11665115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586019 [patent_doc_number] => 20090105221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'MUSCARINIC RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/576096 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16064 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105221.pdf [firstpage_image] =>[orig_patent_app_number] => 11576096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840397 [patent_doc_number] => 20080280883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Muscarinic Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/575825 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19491 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280883.pdf [firstpage_image] =>[orig_patent_app_number] => 11575825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769220 [patent_doc_number] => 20060019942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Metal complex glycogen synthase kinase 3 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/228381 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18179 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019942.pdf [firstpage_image] =>[orig_patent_app_number] => 11228381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281960 [patent_doc_number] => 07553960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Phthalocyanine compound' [patent_app_type] => utility [patent_app_number] => 11/228305 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4369 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553960.pdf [firstpage_image] =>[orig_patent_app_number] => 11228305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705156 [patent_doc_number] => 20080064680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Methods for Diagnosis and Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 10/564981 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 32117 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10564981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217162 [patent_doc_number] => 07612072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor' [patent_app_type] => utility [patent_app_number] => 11/660722 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6045 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612072.pdf [firstpage_image] =>[orig_patent_app_number] => 11660722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808177 [patent_doc_number] => 20080171755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Pyrimidinylpyrazoles as Tgf-Beta Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/661531 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15181 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171755.pdf [firstpage_image] =>[orig_patent_app_number] => 11661531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521984 [patent_doc_number] => 20090029965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Vasopressin V1a Antagonists' [patent_app_type] => utility [patent_app_number] => 11/659798 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93718 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029965.pdf [firstpage_image] =>[orig_patent_app_number] => 11659798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916295 [patent_doc_number] => 20080096896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Cyclic Amide & Ester Pyrazinoylganidine Sodium Channel Blockers' [patent_app_type] => utility [patent_app_number] => 11/573693 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20053 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096896.pdf [firstpage_image] =>[orig_patent_app_number] => 11573693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801930 [patent_doc_number] => 20060036093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Pyrimidinone compounds' [patent_app_type] => utility [patent_app_number] => 11/204792 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15493 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20060036093.pdf [firstpage_image] =>[orig_patent_app_number] => 11204792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189147 [patent_doc_number] => 20070167456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Mercaptoimidazoles as ccr2 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/572770 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14248 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167456.pdf [firstpage_image] =>[orig_patent_app_number] => 11572770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5809562 [patent_doc_number] => 20060095918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'System, apparatus, method, and computer program for processing information' [patent_app_type] => utility [patent_app_number] => 11/195826 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 29525 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20060095918.pdf [firstpage_image] =>[orig_patent_app_number] => 11195826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211034 [patent_doc_number] => 20070249618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression' [patent_app_type] => utility [patent_app_number] => 11/572966 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10291 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249618.pdf [firstpage_image] =>[orig_patent_app_number] => 11572966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185159 [patent_doc_number] => 07648984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Antibacterial agents' [patent_app_type] => utility [patent_app_number] => 11/570600 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15260 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648984.pdf [firstpage_image] =>[orig_patent_app_number] => 11570600 [rel_patent_id] =>[rel_patent_doc_number] =>)